Shanghai Fosun Pharmaceutical Group Co Ltd revenue for the last year amounted to 5.81 B USD, the most of which — 4.28 B USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 4.59 B USD. The greatest contribution to the revenue figure was made by China — last year it brought Shanghai Fosun Pharmaceutical Group Co Ltd 4.39 B USD, and the year before that — 4.47 B USD.